US$ 22.88
aod9604 igf-1 levels study AOD 9604 - 5MG AOD-9604 vs. Tesamorelin vs. Semaglutide:
Description
Maintenance dose is given as per need

Products are for qualified researchers in academic, pharmaceutical or biotechnology settings with appropriate training and facilities

Larger individuals with more adipose tissue benefit from doses at the upper end of standard ranges

& Willing, B
This makes the peptide suitable for research in populations with diabetes or pre-diabetes, where insulin sensitivity is already compromised

This may help explain why it is little used by health professionals
